Literature DB >> 25605640

Nitrate's effect on activity tolerance in heart failure with preserved ejection fraction trial: rationale and design.

Rosita Zakeri1, James A Levine1, Gabriel A Koepp1, Barry A Borlaug1, Julio A Chirinos1, Martin LeWinter1, Peter VanBuren1, Victor G Dávila-Román1, Lisa de Las Fuentes1, Prateeti Khazanie1, Adrian Hernandez1, Kevin Anstrom1, Margaret M Redfield2.   

Abstract

Entities:  

Keywords:  accelerometry; clinical trial; heart failure, diastolic

Mesh：

Substances：

Year:  2015        PMID： 25605640      PMCID： PMC4304404          DOI： 10.1161/CIRCHEARTFAILURE.114.001598

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN： 1941-3289            Impact factor:   8.790


× No keyword cloud information.
  69 in total

1.  A novel method--the activity log index--for monitoring physical activity of patients with heart failure.

Authors:  Veerichetty A Kadhiresan; Joseph Pastore; Angelo Auricchio; Stefan Sack; Annette Doelger; Steven Girouard; Julio C Spinelli
Journal:  Am J Cardiol       Date:  2002-06-15       Impact factor: 2.778

2.  Implications of coronary artery disease in heart failure with preserved ejection fraction.

Authors:  Seok-Jae Hwang; Vojtech Melenovsky; Barry A Borlaug
Journal:  J Am Coll Cardiol       Date:  2014-04-23       Impact factor: 24.094

3.  Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly.

Authors:  C H Chen; M Nakayama; E Nevo; B J Fetics; W L Maughan; D A Kass
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

Review 4.  Assessment of functional status in patients with cardiac disease.

Authors:  K S Coyne; J K Allen
Journal:  Heart Lung       Date:  1998 Jul-Aug       Impact factor: 2.210

5.  Randomized, double-blind crossover study to investigate the effects of amlodipine and isosorbide mononitrate on the time course and severity of exercise-induced myocardial stunning.

Authors:  C A Rinaldi; A Z Linka; N D Masani; P G Avery; E Jones; H Saunders; R J Hall
Journal:  Circulation       Date:  1998-08-25       Impact factor: 29.690

6.  Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension.

Authors:  Gordon S Stokes; Edward S Barin; Kerry L Gilfillan
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

7.  Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug.

Authors:  T Münzel; S Kurz; S Rajagopalan; M Thoenes; W R Berrington; J A Thompson; B A Freeman; D G Harrison
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

8.  Randomized, double-blind, placebo-controlled study of carvedilol on the prevention of nitrate tolerance in patients with chronic heart failure.

Authors:  H Watanabe; M Kakihana; S Ohtsuka; Y Sugishita
Journal:  J Am Coll Cardiol       Date:  1998-11       Impact factor: 24.094

9.  Physical activity measured with implanted devices predicts patient outcome in chronic heart failure.

Authors:  Viviane M Conraads; Martijn A Spruit; Frieder Braunschweig; Martin R Cowie; Luigi Tavazzi; Martin Borggrefe; Michael R S Hill; Sandra Jacobs; Bart Gerritse; Dirk J van Veldhuisen
Journal:  Circ Heart Fail       Date:  2014-02-11       Impact factor: 8.790

10.  Nitrate therapy for heart failure: benefits and strategies to overcome tolerance.

Authors:  Divya Gupta; Vasiliki V Georgiopoulou; Andreas P Kalogeropoulos; Catherine N Marti; Clyde W Yancy; Mihai Gheorghiade; Gregg C Fonarow; Marvin A Konstam; Javed Butler
Journal:  JACC Heart Fail       Date:  2013-06-03       Impact factor: 12.035
View more
  13 in total

Review 1.  Novel paradigms in the therapeutic management of heart failure with preserved ejection fraction: clinical perspectives.

Authors:  Fayez El Shear
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

2.  Comparing Measures to Assess Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction.

Authors:  Rebecca Napier; Steven E McNulty; David T Eton; Margaret M Redfield; Omar AbouEzzeddine; Shannon M Dunlay
Journal:  JACC Heart Fail       Date:  2018-06-06       Impact factor: 12.035

3.  Healthy Immigrant Families: Randomized Controlled Trial of a Family-Based Nutrition and Physical Activity Intervention.

Authors:  Mark L Wieland; Marcelo M M Hanza; Jennifer A Weis; Sonja J Meiers; Christi A Patten; Matthew M Clark; Jeff A Sloan; Paul J Novotny; Jane W Njeru; Adeline Abbenyi; James A Levine; Miriam Goodson; Graciela D Porraz Capetillo; Ahmed Osman; Abdullah Hared; Julie A Nigon; Irene G Sia
Journal:  Am J Health Promot       Date:  2017-11-29

4.  Comparison of the Kansas City Cardiomyopathy Questionnaire and Minnesota Living With Heart Failure Questionnaire in Predicting Heart Failure Outcomes.

Authors:  Derek Yee; Eric Novak; Anne Platts; Michael E Nassif; Shane J LaRue; Justin M Vader
Journal:  Am J Cardiol       Date:  2018-12-04       Impact factor: 2.778

5.  Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction.

Authors:  Melissa A Lyle; Seethalakshmi R Iyer; Margaret M Redfield; Yogesh N V Reddy; G Michael Felker; Thomas P Cappola; Adrian F Hernandez; Christopher G Scott; John C Burnett; Naveen L Pereira
Journal:  JACC Heart Fail       Date:  2019-08-07       Impact factor: 12.035

6.  Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices.

Authors:  David Snipelisky; Jacob Kelly; James A Levine; Gabriel A Koepp; Kevin J Anstrom; Steven E McNulty; Rosita Zakeri; G Michael Felker; Adrian F Hernandez; Eugene Braunwald; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2017-06       Impact factor: 8.790

7.  Healthy immigrant families: Participatory development and baseline characteristics of a community-based physical activity and nutrition intervention.

Authors:  Mark L Wieland; Jennifer A Weis; Marcelo M K Hanza; Sonja J Meiers; Christi A Patten; Matthew M Clark; Jeff A Sloan; Paul J Novotny; Jane W Njeru; Adeline Abbenyi; James A Levine; Miriam Goodson; Maria Graciela D Porraz Capetillo; Ahmed Osman; Abdullah Hared; Julie A Nigon; Irene G Sia
Journal:  Contemp Clin Trials       Date:  2015-12-04       Impact factor: 2.226

Review 8.  Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?

Authors:  Sumeet S Mitter; Sanjiv J Shah
Journal:  Curr Atheroscler Rep       Date:  2015-11       Impact factor: 5.113

Review 9.  The Nitrate-Nitrite-NO Pathway and Its Implications for Heart Failure and Preserved Ejection Fraction.

Authors:  Julio A Chirinos; Payman Zamani
Journal:  Curr Heart Fail Rep       Date:  2016-02

10.  Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.

Authors:  Margaret M Redfield; Kevin J Anstrom; James A Levine; Gabe A Koepp; Barry A Borlaug; Horng H Chen; Martin M LeWinter; Susan M Joseph; Sanjiv J Shah; Marc J Semigran; G Michael Felker; Robert T Cole; Gordon R Reeves; Ryan J Tedford; W H Wilson Tang; Steven E McNulty; Eric J Velazquez; Monica R Shah; Eugene Braunwald
Journal:  N Engl J Med       Date:  2015-11-08       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.